 Source: Minerva Studio Shutterstock.com Better Therapeutics NASDAQ: BTTX stock is rocketing higher on Thursday as investors react to results from a Phase 2 clinical trial. This Phase 2 study saw Better Therapeutics using BT-001 to treat type 2 diabetes. 